Dioscin exerts many therapeutic effects on various diseases [32, 33], such as regulating the inhibitory effect of miR-125a-5p on STAT3 signaling and reducing glucose and lipid metabolism disorders in Type 2 diabetes (T2DM) suggesting that it exhibits anti-T2DM activity [34]. The gene discussed is STAT3; the disease is Disorder of lipid metabolism.